Envestnet Asset Management Inc Bicycle Therapeutics PLC Transaction History

Envestnet Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$12.95 - $46.99 $468,323 - $1.7 Million	-36,164 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$40.12 - $59.5 $205,735 - $305,116	-5,128 Reduced 12.42%	36,164 $1.59 Million
Q4 2021 Feb 04, 2022	SELL	$41.7 - $61.14 $83,566 - $122,524	-2,004 Reduced 4.63%	41,292 $2.51 Million
Q3 2021 Oct 07, 2021	BUY	$27.95 - $44.24 $17,636 - $27,915	631 Added 1.48%	43,296 $1.8 Million
Q2 2021 Aug 04, 2021	BUY	$27.0 - $32.28 $1.15 Million - $1.38 Million	42,665 New	42,665 $1.3 Million

30.6M

85.5K

11.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $600M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.